CLOV - Earnings announcements

WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will release its financial results after the market closes on Wednesday, May 6, 2026. The Company's management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance for the quarter. First Quarter 2026 Conference Webcast Details: What: Clover Health's First Quarter 2026 Earnings Conference CallWhen: Wednesday, May 6, 2026, at 5:00 p.m. Eastern TimeWebcast: To access the webcast, you may register at https://clover-health-1q26-earnings-call.ope

Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull year 2025 Total revenues of $1.9 billion, up 40% year-over-yearFull year 2025 GAAP Net loss of $86 million, Adjusted EBITDA of $22 million, and Adjusted Net Income of $20 million Full Year 2026 Gu

WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will release its financial results after the market closes on Thursday, February 26, 2026. The Company's management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance for the quarter. Fourth Quarter and Full Year 2025 Conference Webcast Details: What: Clover Health's Fourth Quarter and Full Year 2025 Earnings Conference CallWhen: Thursday, February 26, 2026, at 5:00 p.m. Eastern TimeWebcast: To access the webcast, you may register at https

Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member baseHigh coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-market growth, and profitable returning member cohorts position Clover for improved positive FY26 Financial Results Financial Results: Third quarter 2025 Medicare Advantage membership of 109,226, up 35% year-over-yearThird quarter 2025 Total revenues of $497 million, up 50% year-over-yearThird quarter 2

WILMINGTON, Del., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today announced that it will release its financial results after the market closes on Tuesday, November 4, 2025. The Company's management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance for the quarter. Third Quarter 2025 Conference Webcast Details: What: Clover Health's Third Quarter 2025 Earnings Conference CallWhen: Tuesday, November 4, 2025, at 5:00 p.m

Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-yearSecond quarter 2025 Total revenues of $478 million, up 34% year-over-yearSecond quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $17 million, and Adjusted Net income of $17 million Updates Full Year 2025 Guidance: Increases Average Medicare Advantage membership to 104,000 - 108,000, representing 32% growth year-over-year at the midpointMaintains Insurance revenue between $1.800 billion and $1.875 billion, representing 37% growth year-over-year at the midpointImproves Adjusted SG&A to between $335 million and $345 million, representing Adjusted SG&A as a percentage

WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will release its financial results after the market closes on Tuesday, August 5, 2025. Company management will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance for the quarter. Second Quarter 2025 Conference Call and Webcast Details: What: Clover Health's Second Quarter 2025 Earnings Conference CallWhen: Tuesday, August 5, 2025, at 5:00 p.m. Eastern TimeDial In: To access the call via telephone please dial 800-245-3047 (for U.S. caller

First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-yearFirst quarter 2025 Total revenues of $462 million, up 33% year-over-yearMedicare Advantage medical costs are in line with expectations, underscoring the strength of Clover's technology-first care management modelMeaningful improvement across first quarter 2025 profitability metrics: GAAP Net loss of $1 million, as compared to a GAAP Net loss of $19 million a year agoAdjusted EBITDA of $26 million, up 279% year-over-yearAdjusted Net income of $25 million, up 322% year-over-year Improved Full Year 2025 Guidance: Average Medicare Advantage membership of 103,000 - 107,000, representing 30% growth year-over-year

WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will report first quarter 2025 financial results after market close on Tuesday, May 6, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 6, 2025, to discuss Clover Health's first quarter 2025 business and financial results. First Quarter 2025 Conference Call and Webcast Details: What: Clover Health's First Quarter 2025 Earnings Conference CallWhen: Tuesday, May 6, 2025, at 5:00 p.m. Eastern TimeDial In: To access the call via telephone please dial 800-274-8461 (for U.S. callers) or

Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-year Company well positioned to invest in membership growth and Clover Assistant technology, while maintaining strong profitability Issues full year 2025 guidance: Average Medicare Advantage membership of 103,000 - 107,000, representing 30% growth year-over-year at the midpointInsurance revenue between $1.800 billion and $1.875 billion, representing 37% growth year-over-year at the midpointAdjusted EBITDA profitability between $45 million and $70 millionAdjusted Net income between

WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover Health"), today announced that it will report fourth quarter and full year 2024 financial results after market close on Thursday, February 27, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on February 27, 2025, to discuss Clover Health's fourth quarter and full year 2024 business and financial results. Fourth Quarter and Full Year 2024 Conference Call and Webcast Details: What: Clover Health's Fourth Quarter and Full Year 2024 Earnings Conference CallWhen: Thursday, February 27, 2025, at 5:00 p.m. Eastern TimeDial In: To access the call via tele

Delivers 9% Total Revenue growth year-to-date compared to prior year period Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over-year Increases Full-Year 2024 guidance midpoint to target updated range of Adjusted EBITDA profitability of $55 million - $65 million, strongly positioning the Company to invest in membership growth opportunity for 2025 FRANKLIN, Tenn., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today reported financial results for the third quarter 2024. Management will host a co

FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover Health"), today announced that it will report third quarter 2024 financial results after market close on Wednesday, November 6, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2024, to discuss Clover Health's third quarter 2024 business and financial results. Third Quarter 2024 Conference Call and Webcast Details: What: Clover Health's Third Quarter 2024 Earnings Conference CallWhen: Wednesday, November 6, 2024, at 5:00 p.m. Eastern TimeDial In: To access the call via telephone please dial 800-579-2543 (for U.S. callers) or 785-424-1

Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP loss of $28.9 million Adjusted EBITDA profitability for the Second Quarter of 2024 of $36.2 million versus Second Quarter 2023 Adjusted EBITDA of $9.9 million Increases Full-Year 2024 guidance to Insurance Revenue of $1.35 billion - $1.375 billion and Adjusted EBITDA profitability of $50 million - $65 million FRANKLIN, Tenn., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enab

FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover Health"), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarter 2024 financial results after market close on Monday, August 5, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on August 5, 2024, to discuss Clover Health's business and financial results. Second Quarter 2024 Conference Call and Webcast Details: What: Clover Health's Second Quarter 2024 Earnings Conference CallWhen: Monday, August 5, 2024, at 5:00 p.m. Eastern TimeDial I

First Quarter 2024 Insurance Revenue growth of 8% year-over-year First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of $79.7 million First Quarter Adjusted EBITDA profitability of $6.8 million versus prior period loss of $37.5 million Improves 2024 guidance to Insurance Revenue of $1.30 billion - $1.35 billion and Adjusted EBITDA profitability of $10 million - $30 million Maintains strong liquidity position and view that Company has sufficient capital for operating and growth needs. Board of Directors authorizes share repurchase program of up to $20 million of the Company's Class A Common Stock over the next two years FRANKLIN, Te

FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company's business and financial results. First Quarter 2024 Conference Call and Webcast Details: What: Clover Health First Quarter 2024 Earnings Conference CallWhen: Tuesday, May 7, 2024, at 5:00 p.m. Eastern TimeDial In: To access the call via telephone please dial 800-579-2543 (for U.S. callers) or 785-424-1789 (for calle

Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4% Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year Issues 2024 guidance with Insurance MCR range of 79% - 83% and up to $20 million of Adjusted EBITDA profitability at the high end of the range FRANKLIN, Tenn., March 12, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a managed care company focused on physician enablement, today reported financial results for the fourth quarter and full year 2023. Management will host a conference call today at 5:00 p.m. ET to discuss it

FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will report fourth quarter and full year 2023 financial results after market close on Tuesday, March 12, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on March 12, 2024 to discuss the Company's business and financial results. Fourth Quarter and Full Year 2023 Conference Call and Webcast Details: What: Clover Health Fourth Quarter and Full Year 2023 Earnings Conference CallWhen: Tuesday, March 12, 2024, at 5:00 p.m. Eastern TimeDial In: To access the call via telephone please dial 800-57

Q3 2023 Insurance MCR Improved to 78.5%, bringing year-to-date MCR to 80.8%, and Insurance revenue grew 12% compared to Q3 2022 Company reports Q3 2023 Net Loss of $41.5 million and Adjusted EBITDA loss of $5.1 million Revised full-year 2023 guidance now reflects Insurance MCR of 81% - 82% and Adjusted EBITDA of ($55) million - ($80) million FRANKLIN, Tenn., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the third quarter 2023. Management will host a conference call t

FRANKLIN, Tenn., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report third quarter 2023 financial results after market close on Monday, November 6, 2023. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2023 to discuss the Company's business and financial results. Third Quarter 2023 Conference Call and Webcast Details: What: Clover Health Third Quarter 2023 Earnings Conference CallWhen: Monday, November 6, 2023, at 5:00 p.m. Eastern

Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2%, bringing first half MCR to 81.9% Company reports Q2 Net Loss of $28.8 million, and Adjusted EBITDA profit of $10.0 million Improved 2023 guidance includes Insurance MCR of 83% - 85%, and Adjusted EBITDA of ($70) million - ($120) million FRANKLIN, Tenn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the second quarter 2023. Management will host a conference cal

FRANKLIN, Tenn., July 11, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarter 2023 financial results after market close on Tuesday, August 8, 2023. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company's business and financial results. Second Quarter Conference Call and Webcast Details: What: Clover Health Second Quarter 2023 Earnings Conference CallWhen: Tuesday, August 8, 2023, at 5:00 p.m. ETDial In: To access

Insurance revenue grew by 14% over Q1'22 Insurance and Non-Insurance MCR improved to 86.6% and 96.1%, respectively Improved 2023 guidance includes Insurance MCR of 87% - 89%, Insurance revenue of $1.18 billion - $1.23 billion, and Adjusted EBITDA of ($125) million - ($175) million FRANKLIN, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the first quarter 2023. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and

FRANKLIN, Tenn., April 11, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report first quarter 2023 financial results after market close on Tuesday, May 9, 2023. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company's business and financial results. First Quarter Conference Call and Webcast Details: What: Clover Health First Quarter 2023 Earnings Conference CallWhen: Tuesday, May 9, 2023, at 5:00 p.m. ETDial In: To access the cal

Q4 2022 Insurance MCR of 92.4% and FY 2022 Insurance MCR of 91.8% 2023 guidance Insurance MCR range of 89% - 91%, and Non-Insurance MCR range of 98% to 100% Strong liquidity expected to meet 2023 operating requirements FRANKLIN, Tenn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the fourth quarter and full year 2022. Management will host a conference call today at 8:30 a.m. ET to discuss its operating results and other business highlights. "Our achievements in 2022

FRANKLIN, Tenn., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report fourth quarter and full year 2022 financial results before market open on Tuesday, February 28, 2023. On that day management will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the Company's business and financial results. Fourth Quarter and Full Year Conference Call and Webcast Details: What: Clover Health Fourth Quarter and Full Year 2022 Earnings Conference CallWhen: Tuesday, Febr

Third quarter Insurance MCR of 86.3% and year-to-date Insurance MCR of 91.7% demonstrate positive momentum The Company updates 2022 full year guidance to include improved 2022 Insurance MCR range of 93% to 94% Clover intends to continue to grow Insurance business at above-market rates in 2023 but will moderate growth to prioritize profitability Company outlines strategic reduction in number of ACO REACH participating physicians in 2023; targeting Non-Insurance MCR below 100% The Company reports strong liquidity, delaying any requirement for additional capital at least through 2023 and potentially beyond FRANKLIN, Tenn., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Cor

FRANKLIN, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to improving health equity for seniors, today announced that it will report third quarter 2022 financial results after market close on Monday, November 7, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company's business and financial results. Third Quarter Conference Call and Webcast Details: What: Clover Health Third Quarter 2022 Earnings Conference CallWhen: Monday, November 7, 2022, at 5:00 p.m. ETDial In: To access the call via telephone p

Second quarter total revenue was $846.7 million compared to $412.5 million in second quarter 2021 Lives under Clover Management grew to ~255,000 from ~129,000 year-over-year Second quarter Insurance (Medicare Advantage) Medical Care Ratio ("MCR") of 92.1% shows significant improvement year-over-year FRANKLIN, Tenn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to improving health equity for seniors, today reported financial results for the second quarter of 2022. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other

FRANKLIN, Tenn., July 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to improving health equity for seniors, today announced that it will report second quarter 2022 financial results after market close on Monday, August 8, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company's business and financial results. Second Quarter Conference Call and Webcast Details: What: Clover Health Second Quarter 2022 Earnings Conference CallWhen: Monday, August 8, 2022, at 5:00 p.m. ETDial In: To access the call via telephone pl

First quarter total revenue was $874.4 million, compared to $200.3 million in first quarter 2021 Lives under Clover Management grew to ~257,000 from ~66,000 year-over-year First quarter Insurance (Medicare Advantage) Medical Care Ratio (MCR) of 96.4% and Non-Insurance (Direct Contracting) MCR of 99.8% show significant improvement quarter-over-quarter Full-year 2022 revenue expected to be $3.0 billion to $3.4 billion Clover continues to expect 2022 Insurance MCR of 95% to 99% and a further step-wise improvement beyond FRANKLIN, Tenn., May 09, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover" or the "Company"), a physician enablement company foc

FRANKLIN, Tenn., April 11, 2022 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ:CLOV) ("Clover" or the "Company"), a physician enablement company committed to improving health equity for seniors, today announced that it will report first quarter 2022 financial results after market close on Monday, May 9, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's business and financial results. First Quarter Conference Call and Webcast Details What: Clover Health First Quarter 2022 Earnings Conference CallWhen: Monday, May 9, 2022, at 5:00 p.m. ETDial In: To access the call via telephone please dial 866-518-6930 (for U.S. callers) or

Fourth quarter total revenue was $432.0 million, up 160% year-over-year, enabled by a wide, open network designed to serve all Medicare lives Lives under Clover Assistant Management increased 223% year-over-year 2022 total revenue expected to exceed $3 billion driven by projected 90% year-over-year growth in lives under management Clover expects 2022 operating expenses as a percentage of revenue and the Medical Care Ratio (MCR) for its Medicare Advantage (MA) plans to decrease meaningfully from 2021 FRANKLIN, Tenn., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ:CLOV) ("Clover" or the "Company"), a next-generation healthcare comp

NASHVILLE, Tenn., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ:CLOV), a technology company committed to improving health equity for America's underserved seniors, today announced that it will report fourth quarter and full year 2021 financial results after market close on Wednesday, February 23, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's business and financial results. Fourth Quarter and Full Year Conference Call and Webcast Details What: Clover Health Fourth Quarter and Full Year 2021 Earnings Conference CallWhen: Wednesday, February 23, 2022, at 5:00 p.m. ETDial In: To access the call via telephone

Total revenue was $427.2 million, up 153% year-over-year, enabled by a wide, open network designed to serve all Medicare lives Lives under Clover Management increased 125% year-over-year GAAP Medicare Advantage (MA) Medical Care Ratio (MCR) improved by 850 basis points compared to the prior quarter MA PPO plan focused on underserved communities and offering a wide provider network was awarded 3.5 Stars Clover provides preliminary 2022 MA guidance: Average MA Lives of 82,000, up 20% plus year-over-year, and MA MCR in the range of 95% to 99% NASHVILLE, Tenn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ:CLOV) ("Clover" or the "Company"), a next-generation healthcare company f

NASHVILLE, Tenn., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ:CLOV), a technology company committed to improving health equity for America's underserved seniors, today announced that it will report third quarter 2021 financial results after market close on Monday, November 8, 2021. Management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's business and financial results. Third Quarter Conference Call and Webcast Details What: Clover Health Third Quarter 2021 Earnings Conference CallWhen: Monday, November 8, 2021, at 5:00 p.m. ETWebcast: A live and archived webcast of the conference call will be accessible from the Investor Relations

Total revenue was $412 million, up 140% year-over-year Lives under Clover Management nearly doubled from the first quarter to approximately 129,000 Clover Assistant on track to manage over $1 billion of annualized revenue NASHVILLE, Tenn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ:CLOV) ("Clover" or the "Company"), a next-generation healthcare company focused on improving health outcomes for America's seniors, today reported financial results for the second quarter of 2021. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights. "Clover took another step in its journey to improve every life with the lau

NASHVILLE, Tenn., July 21, 2021 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ:CLOV), an innovative technology company committed to improving health equity for America's underserved seniors, today announced that it will report second quarter 2021 financial results after market close on Wednesday, August 11, 2021. Management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's business and financial results. Second Quarter Conference Call and Webcast Details What: Clover Health Second Quarter 2021 Earnings Conference CallWhen: Wednesday, August 11, 2021, at 5:00 p.m. ETWebcast: A live and archived webcast of the conference call will be accessible from the